Shaoyi Lin

机构：The First People's Hospital of Shunde, Foshan Hospital of TCM

发表论文 35 篇 · 总被引 352 次 · h-index 10

代表论文

• The Role of Transcription Factor 21 in Epicardial Cell Differentiation and the Development of Coronary Heart Disease (2020 · Frontiers in Cell and Developmental Biology · 被引 48)
• The promising novel therapies for familial hypercholesterolemia (2022 · Journal of Clinical Laboratory Analysis · 被引 32)
• Novel design of nano-selenium loaded injectable hydrogel combined with mesenchymal stem cells-derived exosomes improving cardiac repair and nursing care after acute myocardial infarction (2023 · Journal of Drug Delivery Science and Technology · 被引 21)
• Calcified Aortic Valve Disease in Patients With Familial Hypercholesterolemia (2020 · Journal of Cardiovascular Pharmacology · 被引 21)
• Ideal Cardiovascular Health Metrics and Incidence of Ischemic Stroke Among Hypertensive Patients: A Prospective Cohort Study (2020 · Frontiers in Cardiovascular Medicine · 被引 14)
• The LDLR c.501C>A is a disease-causing variant in familial hypercholesterolemia (2021 · Lipids in Health and Disease · 被引 8)